Bliss GVS Pharma Limited (BOM:506197)
India · Delayed Price · Currency is INR 153.70
-3.35 (-2.13%)
At close: Jan 21, 2026
Bliss GVS Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 1,096 | 842.99 | 754.54 | 708.59 | 150.4 | 684.91 | Upgrade |
Depreciation & Amortization | 319.53 | 293.21 | 262.57 | 185.13 | 171.33 | 170.27 | Upgrade |
Other Amortization | 0.97 | 0.97 | 1.23 | 1.61 | 1.98 | 2.03 | Upgrade |
Loss (Gain) From Sale of Assets | 27.52 | 4.92 | -2.86 | -3.65 | -1.38 | 0.31 | Upgrade |
Loss (Gain) From Sale of Investments | 116.03 | -4.91 | - | - | - | - | Upgrade |
Stock-Based Compensation | 48.3 | 41.4 | 38.16 | 39.04 | 57.08 | 98.38 | Upgrade |
Provision & Write-off of Bad Debts | 196.47 | 124.09 | 252.74 | 228.07 | 227.8 | 39.57 | Upgrade |
Other Operating Activities | 223.48 | 271.03 | 187.5 | 35.54 | 13.87 | 223.09 | Upgrade |
Change in Accounts Receivable | -745.82 | -446.54 | -445.19 | -149.98 | 512.91 | 629.26 | Upgrade |
Change in Inventory | -185.17 | -304.54 | -224.22 | 150.03 | -290.97 | -268.01 | Upgrade |
Change in Accounts Payable | 92.16 | 108.38 | -251 | -63.16 | 183.44 | -146.76 | Upgrade |
Change in Other Net Operating Assets | 169.17 | 128.15 | 454.7 | -788.08 | 328.34 | -793.35 | Upgrade |
Operating Cash Flow | 1,359 | 1,059 | 1,028 | 343.14 | 1,355 | 639.69 | Upgrade |
Operating Cash Flow Growth | 29.36% | 3.01% | 199.64% | -74.67% | 111.79% | 36.97% | Upgrade |
Capital Expenditures | -711.59 | -760.65 | -283.29 | -937.99 | -740.03 | -91.24 | Upgrade |
Sale of Property, Plant & Equipment | 126.33 | 34.12 | 6.03 | 6.91 | 10.68 | 4.21 | Upgrade |
Investment in Securities | -502.85 | -222.19 | 539.54 | -54.58 | -22.31 | -436.89 | Upgrade |
Other Investing Activities | 197.87 | 194.31 | -1,094 | 908.15 | -178.09 | 53.87 | Upgrade |
Investing Cash Flow | -807.34 | -754.41 | -831.9 | -77.51 | -929.75 | -469.91 | Upgrade |
Long-Term Debt Issued | - | 552.73 | 154.88 | 400.22 | 107.56 | 96.65 | Upgrade |
Long-Term Debt Repaid | - | -762.34 | -272.36 | -552.68 | -284.81 | -185.94 | Upgrade |
Net Debt Issued (Repaid) | -471.01 | -209.61 | -117.48 | -152.46 | -177.26 | -89.29 | Upgrade |
Issuance of Common Stock | 16.4 | 28.86 | 23.5 | 20.42 | 22.84 | - | Upgrade |
Common Dividends Paid | -55.07 | -54.49 | -53.95 | -54.37 | -53.27 | -55.5 | Upgrade |
Other Financing Activities | -87.32 | -68.21 | -61 | -62.97 | -29.62 | -63.2 | Upgrade |
Financing Cash Flow | -596.99 | -303.45 | -208.93 | -249.39 | -237.3 | -207.98 | Upgrade |
Foreign Exchange Rate Adjustments | -1.76 | 0.99 | -1.5 | 13.96 | -99.23 | 16.15 | Upgrade |
Net Cash Flow | -47.16 | 2.26 | -14.16 | 30.2 | 88.53 | -22.05 | Upgrade |
Free Cash Flow | 647.34 | 298.48 | 744.87 | -594.86 | 614.78 | 548.45 | Upgrade |
Free Cash Flow Growth | 7.63% | -59.93% | - | - | 12.09% | - | Upgrade |
Free Cash Flow Margin | 7.52% | 3.69% | 9.67% | -7.92% | 8.22% | 9.50% | Upgrade |
Free Cash Flow Per Share | 6.10 | 2.81 | 7.02 | -5.64 | 5.84 | 5.20 | Upgrade |
Cash Interest Paid | 87.09 | 68.21 | 61 | 62.97 | 29.62 | 63.2 | Upgrade |
Cash Income Tax Paid | 376.37 | 366.36 | 348.51 | 445.55 | 339.43 | 285.63 | Upgrade |
Levered Free Cash Flow | -47.67 | 125.25 | 19.06 | -184.61 | 1,059 | 691.96 | Upgrade |
Unlevered Free Cash Flow | 20.48 | 173.68 | 56.88 | -122.96 | 1,082 | 718.84 | Upgrade |
Change in Working Capital | -669.66 | -514.56 | -465.71 | -851.19 | 733.73 | -578.86 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.